Thursday, July 1, 2010

Nerve Center Test Gets First Post-SCOTUS Application

The Legal Intelligencer reports on a recent ruling that GlaxoSmithKline is a citizen of Pennsylvania (where it has its corporate headquarters), preventing removal of a products liability case to federal court.  This marks a change from the pre-Hertz decisions where courts in circuits that did not apply the nerve center test would hold that such companies are citizens of a state in which most major manufacturing takes place.

RJE

http://lawprofessors.typepad.com/civpro/2010/07/nerve-center-test-gets-first-postscotus-application.html

Federal Courts, Recent Decisions | Permalink

Comments

Post a comment